India's Weight-Loss Drug Boom: Benefits and Risks

India is experiencing a significant surge in the demand for weight-loss drugs, particularly in urban areas. These medications, originally developed for diabetes treatment, are now being hailed as game-changers for weight loss. They work by mimicking a natural hormone that regulates hunger, making people feel full faster and for longer periods.

Two drugs dominate the market: semaglutide and tirzepatide. They're typically self-injected weekly and can lead to substantial weight loss. However, doctors warn that users may regain weight after stopping the medication, and prolonged use without exercise can lead to muscle loss.

The market for these drugs has grown dramatically, from $16 million in 2021 to nearly $100 million today. While this boom offers new options for those struggling with obesity, it also raises concerns. There are reports of misuse, with some people obtaining the drugs without proper medical supervision. Doctors emphasize that these medications should be used as part of a comprehensive approach to weight management, including diet and exercise, rather than as a quick fix.